Gender disparity observed in cancer genetic testing in the U.S.

May 3, 2018

(HealthDay)—Specific demographic groups have lower cancer genetic testing, including unaffected men compared with unaffected women, according to a research letter published online April 26 in JAMA Oncology.

Kimberly K. Childers, from Providence Health & Services Southern California in Los Angeles, and colleagues described the U.S. national distribution of genetic testing for hereditary risk and examined whether a exists in testing. Data were obtained from the 2015 U.S. National Health Interview Survey.

The researchers found that 378 adults reported a history of genetic testing for cancer, representing 2,498,842 people. In the testing subsample, there was a lower proportion of Hispanics (10 versus 16 percent), uninsured individuals (2 versus 10 percent), noncitizens (4 versus 8 percent), and those with less education (high school or General Education Development diploma: 30 versus 44 percent). Many more women than men received testing (73 versus 27 percent); this disparity persisted for unaffected men versus unaffected women (rate ratio, 0.51). Genetic testing was mainly for breast/ovarian cancer (76 percent), with 24 percent for colorectal cancer and 22 percent for other cancers. Among the unaffected, the rate of testing for breast/ovarian cancer for men was one-tenth of that for women (rate ratio, 0.1). No gender disparity was seen for colorectal or other cancer testing.

"Cancer seems to reach a broad geographic and sociodemographic population in this national survey. However, there remain underrepresented groups," the authors write.

Explore further: Breast cancer genes a real risk for men, too

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Breast cancer genes a real risk for men, too

April 26, 2018
(HealthDay)—Few American men are screened for gene mutations that can greatly increase their risk of breast and other types of cancers, a new study reveals.

Busting myths surrounding cancer and genetic testing

April 13, 2018
(HealthDay)—While only 5 percent to 10 percent of cancers are caused by an inherited gene mutation, genetic testing may benefit people with a strong history of family cancer, an expert in genetics suggests.

Mutations common in pancreatic CA, history of other cancers

February 7, 2018
(HealthDay)—A substantial proportion of individuals with pancreatic cancer and a history of other hereditary breast and ovarian cancer (HBOC)- or Lynch syndrome (LS)-related cancers have mutations in a prostate cancer susceptibility ...

Use of MMR deficiency testing in younger CRC patients is low

November 13, 2017
(HealthDay)—Fewer than half of younger adults with colorectal cancer (CRC) undergo mismatch repair (MMR) deficiency of DNA testing, according to a study published online Nov. 9 in JAMA Oncology.

Higher positive cardiomyopathy genetic detection rates for whites

March 5, 2018
(HealthDay)—Compared with underrepresented minorities, white individuals have significantly higher positive detection rates and lower rates of inconclusive results on cardiomyopathy genetic testing, according to a study ...

Few women with history of breast cancer and ovarian cancer take a recommended genetic test

August 21, 2017
Of the nearly 4 million women in the United States who have had either breast cancer or ovarian cancer, at least 1.5 million have a high risk of carrying certain types of genetic mutations that could increase their risk for ...

Recommended for you

Scientists discover chemical which can kill glioblastoma cells

August 15, 2018
Aggressive brain tumour cells taken from patients self-destructed after being exposed to a chemical in laboratory tests, researchers have shown.

Three scientists share $500,000 prize for work on cancer therapy

August 15, 2018
Tumors once considered untreatable have disappeared and people previously given months to live are surviving for decades thanks to new therapies emerging from the work of three scientists chosen to receive a $500,000 medical ...

PARP inhibitor improves progression-free survival in patients with advanced breast cancers

August 15, 2018
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over ...

New clues into how 'trash bag of the cell' traps and seals off waste

August 15, 2018
The mechanics behind how an important process within the cell traps material before recycling it has puzzled scientists for years. But Penn State researchers have gained new insight into how this process seals off waste, ...

RUNX proteins act as regulators in DNA repair, study finds

August 15, 2018
A study by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore has revealed that RUNX proteins are integral to efficient DNA repair via the Fanconi Anemia (FA) ...

Chemicals found in vegetables prevent colon cancer in mice

August 14, 2018
Chemicals produced by vegetables such as kale, cabbage and broccoli could help to maintain a healthy gut and prevent colon cancer, a new study from the Francis Crick Institute shows.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.